S&P 500
(0.25%) 5 487.03 points
Dow Jones
(0.15%) 38 835 points
Nasdaq
(0.03%) 17 862 points
Oil
(0.25%) $81.77
Gas
(0.45%) $2.92
Gold
(-0.15%) $2 343.40
Silver
(-0.18%) $29.51
Platinum
(-0.11%) $976.10
USD/EUR
(0.05%) $0.931
USD/NOK
(0.06%) $10.58
USD/GBP
(0.04%) $0.787
USD/RUB
(-0.15%) $85.24

Realtime updates for Northwest [NWBO]

Exchange: PNK Industry: Biotechnology
Last Updated18 Jun 2024 @ 15:59

-5.53% $ 0.470

Live Chart Being Loaded With Signals

Commentary (18 Jun 2024 @ 15:59):
Our systems believe the stock currently is overvalued by -0.05% compare to its pairs and should correct downwards.

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer...

Stats
Today's Volume 1.13M
Average Volume 1.68M
Market Cap 568.51M
EPS $-0.0154 ( Q1 | 2024-05-10 )
Next earnings date ( $0 ) 2024-08-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -6.71
(Sector) 0
(Industry) 0
ATR14 $0.00300 (0.64%)
ABVC -8.31%
ACBM 0.00%
AGTX 0.00%
ARTH -4.99%
ATMS -73.65%
ATRX -74.42%
AXIM 0.00%
BPSR 22.45%
BSTG 0.75%
BZYR 0.00%
CDXI 0.00%
CELZ -5.09%
CLCS 0.00%
CNBX 7.50%
CRYO -99.75%
CYDY 2.21%
ENDV 33.33%
ENZN 6.99%
GBIM -99.00%
GBLX 0.00%
GTBP 2.40%
GTHR -99.98%
HSTC 0.00%
IGXT 0.00%
IMUN -7.00%
INTI 0.00%
IPIX 0.00%
ISCO 0.00%
MCUJF 0.00%
MRZM 0.00%
MYMX 0.00%
NBIO 0.00%
NTRB -5.12%
NTRR 0.00%
NWBO -5.53%
PKTX -9.09%
PMCB -9.13%
PPCB -7.14%
PTIX -3.60%
QBIO -75.00%
QRON -11.68%
RASP 0.00%
RCAR 0.00%
REPCF 4.99%
RGRX 0.00%
SGBI 25.00%
SOAN 16.84%
TAUG 0.00%
TLOG 0.00%
TOMDF 0.00%
TSOI 12.50%
VBIO 11.43%
VSBC 0.00%
XSNX 0.00%
ZIVO 6.40%
Insider Trading
Date Person Action Amount type
2023-11-16 Malik Navid Buy 125 000 Common Stock
2023-11-17 Malik Navid Buy 150 000 Common Stock
2023-11-17 Malik Navid Buy 295 000 Common Stock
2023-04-03 Bosch Marnix L Buy 119 355 Common Stock
2023-04-04 Boynton Alton L Sell 6 794 191 STOCK OPTIONS
INSIDER POWER
-78.92
Last 96 transactions
Buy: 331 589 317 | Sell: 61 146 214
Correlation (AI algo v.1.1b): Overvalued: -0.05% $0.470 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.00 (neutral)
Short: 0.28 (neutral)
Signal:(43.192) Neutral

Northwest Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Northwest Correlation - Currency/Commodity

The country flag -0.01
( neutral )
The country flag 0.03
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.27
( neutral )

Northwest Financials

Annual 2023
Revenue: $1.93M
Gross Profit: $199 000 (10.30 %)
EPS: $-0.0559
FY 2023
Revenue: $1.93M
Gross Profit: $199 000 (10.30 %)
EPS: $-0.0559
FY 2022
Revenue: $1.68M
Gross Profit: $135 000 (8.02 %)
EPS: $-0.130
FY 2021
Revenue: $1.01M
Gross Profit: $0.00 (0.00 %)
EPS: $0.210

Financial Reports:

No articles found.

Northwest Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Northwest

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.1083199977875 seconds
Number of API calls: 3
Number of DB calls: 9